✦ LIBER ✦

Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double-blind, placebo-controlled study

✍ Scribed by Robert G. W. Lambert; David Salonen; Proton Rahman; Robert D. Inman; Robert L. Wong; Steven G. Einstein; Glen T. D. Thomson; Andre Beaulieu; Denis Choquette; Walter P. Maksymowych

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 190 KB
Volume: 56
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.23044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Major reduction in spinal inflammation i

Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study

✍ Jürgen Braun; Robert Landewé; Kay-Geert A. Hermann; John Han; Songkai Yan; Paul 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 2 views

## Abstract ## Objective To determine whether the effects of anti–tumor necrosis factor α (TNFα) in reducing the signs and symptoms of ankylosing spondylitis (AS) coincide with a reduction in spinal inflammation as detected by magnetic resonance imaging (MRI). ## Methods Pre‐ and postgadolinium